Clinical Trial Update: A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT ReductioN of DecREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether pre-procedural intracoronary nicorandil can prevent reduced TIMI flow during percutaneous coronary intervention in pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• No-reflow Phenomenon

Drugs mentioned

• Nicorandil (nicorandil)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: No-Reflow Phenomenon, Coronary Artery Disease | Phase 4 | Status: RECRUITING